Community Based Organizations: NH&E Data Training

NHM&E Client Level Variables
Variable #

Variable Name

Variable Definition

A01
A01a

Agency Name
Agency ID

A02

Community Plan Jurisdiction

A27

CBO Agency Name

A28

CBO Agency ID

The official legal name of the agency or organization.
An alpha-numeric identification used to uniquely identify an agency.
The CDC-directly funded state, territory, city area, or region where a state or local health
department receives funding to monitor HIV prevention activities. Each jurisdiction has a
corresponding Federal Information Processing Standards (FIPS) code.
The official name of the directly-funded community-based organization funded by CDC to conduct
HIV prevention activities.
The identification number of a CDC directly-funded community-based organization. This number is
assigned by the CDC.

Site ID

A unique code used to distinguish the locations where an agency delivers the HIV prevention
service. A site ID is linked to the site type and the site zip code. For Partner services (PS) the site
ID is that of the local agency to which the case is assigned.

Site Type

The setting of the location in which HIV prevention services are provided. For HIV testing, CDC
will assume that testing done in a clinical (or health care) setting is part of a screening program
and that testing done in a non-clinical (or non-health care) setting is part of a targeted testing
strategy. For PS the type of local agency to which the PS case is assigned.

S01

S04

Value Description where
applicable

Clinical - Inpatient hospital
Clinical - TB clinic
Clinical - Substance abuse
treatment facility
Clinical - Community health center
Clinical - Emergency department
Non-clinical - HIV testing site
Non-clinical - Community setting School/educational facility

Non-clinical - Community setting Church/mosque/synagogue/temple
Non-clinical - Communtiy Setting Shelter/transitional housing
Non-clinical - Community setting Commercial facility
Non-clinical - Community setting Bar/club/adult entertainment
Non-clinical - Community setting Public area

Variable #

Variable Name

Variable Definition

Value Description where
applicable
Non-clinical – Community setting –
Individual residence
Non-clinical - Community setting Other
Non-clinical - Correctional facility Non-healthcare
Clinical - Primary care clinic (other
than CHC)
Clinical - Pharmacy or other retailbased clinic
Clinical - STD clinic
Clinical - Dental clinic
Clinical - Correctional facility clinic
Clinical - Other
Non-clinical - Health department field visit
Non-clinical - Community Setting Syringe exchange program
Non-clinical - Other

S08

Site - County

S09

Site - State

S10

Site - Zip Code

CDC03

CDC Variable 3

CDC04

CDC Variable 4

CDC05
CDC06
CDC07
CDC08

CDC Variable 5
CDC Variable 6
CDC Variable 7
CDC Variable 8

G101

Date Collected

G103

Local Client ID

The county, parish, or municipality where the agency's site of service delivery is physically
located.
The state, territory or district in which the official mailing address for the site is physically located.
The postal zip code associated with the site where services are provided. The site's postal zip
code is linked to the unique Site ID and Site Type. For PS, this is the zip of the local agency to
which the case is assigned.
This field is reserved for use within the MSM Testing Initiative Project. The specifications are to be
determined (TBD).
This field is reserved for use within the MSM Testing Initiative Project. The specifications are to be
determined (TBD).
This field is reserved for use within the MSM Testing Initiative Project. The specifications are to be
determined (TBD).
TBD
TBD
TBD
The date on which client demographic data are collected. For reporting to CDC, this should be the
intake date or the date of the first session before the intervention begins.
A locally developed client unique key used to distinguish an individual client receiving multiple
services within an agency.

Variable #

Variable Name

Variable Definition

G112

Date of Birth - Year

G114

Ethnicity

The calendar year in which the client was born.
The client's self report of whether they are of Hispanic or Latino origin. Standard OMB ethnicity
codes are applied.

Value Description where
applicable

Declined to answer
Don't know
Hispanic or Latino
Not Hispanic or Latino
G116

Race

A client's self-reported classification or classifications of the biological heritage with which they
most closely identify. Standard OMB race codes are applied.
Declined to answer
Don't know
American Indian or Alaska Native
Asian
Black or African American
Native Hawaiian or Pacific Islander
White

G120

State/Territory of Residence

G123

Assigned Sex at Birth

The state, territory or district where the client was residing at the time of service delivery.
The biological sex assigned to the client at birth, (i.e., the sex noted on the client's birth
certificate).
Male
Female
Declined to answer

G124

Current Gender Identity

The client's current self-reported gender identity. This may include one's social status, selfidentification, legal status, and biology.
Male
Female
Transgender - MTF
Transgender - FTM
Transgender - Unspecified
Declined to answer
Additional (specify)

G124a
G132

Specify Current Gender Identity
Client - County

G200
G204

Date Client Risk Collected
Previous HIV test

The additional specification of Current Gender Identity if G124 = 89 "Additional (specify)".
The county, parish, or municipality of the client's locating address.
The date client risk profile data are collected. For reporting to CDC, this should be the intake date
or the date of the first session before the intervention begins.
The client's self-report of having had at least one prior HIV test.
No
Yes
Not asked
Declined to answer
Don't know

Variable #

Variable Name

Variable Definition

G205

Self Reported HIV Test Result

The client's self-reported result from his/her most recent HIV test.

Value Description where
applicable
Positive
Negative
Preliminary positive
Indeterminate
Not asked
Declined to answer
Don't know

G209

Pregnant (only if female)

The self-reported pregnancy status of the client.
No
Yes
Not asked
Declined to answer
Don't know

G210

In Prenatal Care (only if pregnant)

The self-reported status of the pregnant client's receipt of regular health care during pregnancy.
No
Yes
Not asked
Declined to answer
Don't know

G211_01

Injection Drug Use

The client self-reported use in the past 12 months any illicit injection drugs/substances (including
narcotics, hormones, silicon, etc.). Illicit injection drugs/substances are those for which a client
does not have a prescription (or which the client uses in a way other than is prescribed) or
drugs/substances that are not available over the counter (or which are used in a way other than
intended).
No
Yes
Don't know

G211_08

Share Drug Injection Equipment

The client self-reported that they shared hypodermic needles, syringes, or other injection
equipment. This variable should only be completed if client has reported injection drug use.
No
Yes
Don't know

G212

Additional Client Risk Factors

If the client's risk factors in the past 12 months involve anal or vaginal sexual activity, these are
additional factors that further describe the client's sexual risk for HIV exposure and/or
transmission.
Exchange sex for drugs/money/or
something they needed
While intoxicated and/or high on
drugs

Variable #

Variable Name

Variable Definition

Value Description where
applicable
With person of unknown HIV status
With person who exchanges sex for
drugs/money
With anonymous partner
Diagnosed with a sexually
transmitted disease (STD)
Sex with multiple partners
Oral Sex (optional)
Unprotected vaginal/anal sex with a
person who is an IDU
Uprotected vaginal/anal sex with a
person who is HIV positive
Unprotected vaginal/anal sex in
exchange for drugs/money/or
something they needed
Unprotected vaginal/anal sex with
person who exchanges sex for
drugs/money
Unprotected sex with multiple
partners

G216a

Vaginal or anal sex with a male in the past
12 months

The client self-reported having vaginal or anal sex with a male in the past 12 months.
No
Yes
Don't know

G216b

Vaginal or anal sex with a female in the past
12 months
The client self-reported having vaginal or anal sex with a female in the past 12 months.
No
Yes
Don't know

G216c

Vaginal or anal sex with a transgender
person in the past 12 months

The client self-reported having vaginal or anal sex with a transgender person in the past 12
months.
No
Yes
Don't know

G217a

Vaginal or Anal Sex Without a condom with
a male

The client self-reported having unprotected vaginal or anal sex with a male.
No
Yes
Don't know

G217b

Vaginal or Anal Sex Without a condom with
a female

The client self-reported having unprotected vaginal or anal sex with a female.

Variable #

Variable Name

Variable Definition

Value Description where
applicable
No
Yes
Don't know

G217c

Vaginal or Anal Sex Without a condom with
a transgender person

The client self-reported having unprotected vaginal or anal sex with a transgender person.
No
Yes
Don't know

G218a

Vaginal or Anal Sex with a male IDU

The client self-reported having vaginal or anal sex with an identified IDU male partner in the past
12 months.
No
Yes
Don't know

G218b

Vaginal or Anal Sex with a female IDU

The client self-reported having vaginal or anal sex with an identified IDU female partner in the past
12 months.
No
Yes
Don't know

G218c

Vaginal or Anal Sex with a transgender IDU

The client self-reported having vaginal or anal sex with an identified transgender IDU partner in
the past 12 months.
No
Yes
Don't know

G219a

Vaginal or Anal Sex with HIV-positive male

The client self-reported having vaginal or anal sex with an HIV-positive male partner(s) in the past
12 months.
No
Yes
Don't know

G219b

The client self-reported having vaginal or anal sex with an HIV-positive female partner(s) in the
Vaginal or Anal Sex with HIV-positive female past 12 months.
No
Yes
Don't know

G219c

Vaginal or Anal Sex with HIV-positive
transgender person

The client self-reported having vaginal or anal sex with an HIV-positive transgender partner(s) in
the past 12 months.
No
Yes
Don't know

G220

The client self-reported having vaginal or anal sex with identified MSM partner(s) in the past 12
Vaginal or Anal Sex with MSM (female only) months.
Yes
No

Variable #

G221

Variable Name

Variable Definition

No Client Risk Information

An indication of why behavioral risk data may not be available for the client. A risk may not have
been identified, or identified during the 12 month recall period; the HIV testing provider may not
have asked the client about his or her risks; or, the client was asked but declined to provide
infomation.

Value Description where
applicable

No risk identified
Not asked
Declined to answer
G222

Vaginal or Anal Sex without a condom (PS
only)

The client self-reported having unprotected vaginal or anal sex with a partner during the past 12
months.
No
Yes

G223

Vaginal or Anal Sex with an IDU (PS only)

The client self-reported having vaginal or anal sex with an identified IDU partner in the past 12
months.
No
Yes

H01
H01a

Intervention ID
Intervention Name

A number used to uniquely identify an intervention.
The name of intervention.
Community PROMISE
Healthy Relationships
Holistic Health Recovery
Many Men, Many Voices
Mpowerment
Popular Opinion Leader
RAPP
Safety Counts
SISTA
Street Smart
Together Learning Choices
VOICES/VOCES
WiLLOW
SiHLE
CLEAR
OPTIONS
Focus on Youth with imPact
MIP
D-UP
Sister to Sister
Project START
Connect
SHIELD
Nia

Variable #

Variable Name

Variable Definition

Value Description where
applicable
Cuidate!
Partnership for Health
Personalized Cognitive Counseling
(PCC)
Project AIM
Safe in the City
RESPECT
Comprehensive Risk Counseling
Services
Study / Special Study (specify)
Other (specify)

H01b

Specify Other Intervention Name

H02

Number of planned sessions

H04a
H05

Form ID
Number of completed sessions

A name of intervention if 3.01 - Study / Special Study (specify) or 3.02-Other (specify) was
selected in H01a.
The total number of sessions planned for an intervention. The number of planned sessions can
differ depending on the needs of individual clients (e.g., CRCS).
A code or identification number used to uniquely identify and connect data collected on a
standardized form for a given intervention. This is system and program required for HIV Testing
and optional for other interventions.
The number of sessions completed by the client for a particular intervention.

H06

Session Date

The calendar date (month, day, and year) on which the session was delivered to the client.

PCR101
PCR103
PCR104

Case Number
Case Open Date
Case Close Date

PCR108
PCR109

Date of Report
Reported to Surveillance

A number to uniquely identify a PS case within an agency. This number is system-generated
when establishing a PS case. It can also be an assigned number that is key-entered by the
provider (e.g., interview record number).
The calendar date on which the PS case was opened at this agency.
The calendar date on which the PS case was closed at this agency.
The date on which an index client was newly reported to surveillance as being infected with HIV.
Persons reported to surveillance have not previously been reported to the same health
department surveillance unit.
An indication of whether or not the index client's HIV case was reported to surveillance.
No
Yes
Unknown

PCR200

Date Collected

PCR202a

Local PS ID

PCR207

Partner Type

The date on which information about the partner is initially collected. Information includes partner
type, demographic and risk behaviors of the partner.
This variable is unique to each partner. Each local PS ID is associated with a specific PS case
number (PCR101).
The partner's sex and needle-sharing relationship with the index client. This relationship could
involve sexual relations between the client and the partner, needle-sharing between the client and
partner or both sex and needle-sharing partners.
Sex partner
Needle-sharing partner

Variable #

Variable Name

Variable Definition

Value Description where
applicable
Both sex and needle sharing
partner

PCR209

Notification Plan

The method that will be used to inform the partner that he or she has been potentially exposed to
HIV.
Client notification
Provider notification
Dual notification
Contract
Third-party notification

U01

formID_status

The indicator to define the status of the record. This status indicator is used for HIV testing
records only.
Deleted Record
New Record
Updated Record

U02

FormId_lastModifiedDate

U03

Client ID Status

An indicator to denote the date in which the record was modified based on the status in U01:
formID_Status. This status indicator is used for HIV testing records only.
The indicator to define the status of the record. This status indicator is used for Partner Services
records only.
Deleted Record
New Record
Updated Record

U04

Client ID Last Modified Date

An indicator to denote the date in which the record was modified based on the status in U03:
IndexClientID_Status. This status indicator is used for Partner Services records only.

X103

Test Technology

A description of the type of test or test methods used to screen for HIV antibodies.
Conventional
Rapid
NAAT/RNA Testing
Other

X104

HIV Test Election

An indication of whether the test is linked to a name or is anonymous.
Tested anonymously
Tested confidentially
Test not offered
Declined testing

X105
X110

Sample Date
Test Result

The calendar date (month, day, year) on which the specimen for the HIV test was collected.
The outcome of the current HIV test.
Positive/reactive
Negative
Indeterminate
Invalid

Variable #

Variable Name

Variable Definition

X111

Result Provided

The act of informing the client of the HIV test result.

Value Description where
applicable
No result
No
Yes
Yes, client obtained the result from
another agency

X115

If Result Not Provided, Why

An explanation for why the HIV test result was not provided to the client.
Refused notification
Did not return/could not locate
Obtained results from another
agency
Other

X135

Worker ID

X136

In Surveillance System or Records

A unique ID used to distinguish between persons who are delivering services to clients.
Information obtained via surveillance system or records that verifies whether or not a client who
has tested positive was previously reported to your jurisdiction’s surveillance department as a new
HIV case.
No
Yes
Not checked

X137

Program Announcement or Program
Strategy

The CDC program announcement or program strategy and the category (e.g., Part A, Part B), if
applicable, under which this HIV testing event was conducted. This variable is required to be
completed by health departments and CBOs directly funded by CDC.
PS 12-1201 – Category A
PS 12-1201 – Category B
PS 12-1201 – Category C
PS 11-1113
PS 10-1003
PS 08-803
MSM Testing Initiative
Other (specify)

X137-1

Specify Program Announcement/Strategy

A specification of the funding source for the HIV testing event if ’89 Other-specify’ was selected in
X137 Program Announcement (PA) or Program Strategy (PS).

X302

Attempt to Locate Outcome

The result of a PS provider's attempt to locate the index client or the index client's partner(s).
Unable to locate
Located

X303

Reason for Unsuccessful Attempt

The explanation for why the location attempt was not achieved.
Deceased
Out of jurisdiction
Other (specify)

X303a
X306

Specify Reason for Unsuccessful Attempt
Enrollment Status

A specification for why the client was not located if X303--89 Other (specify) is selected.
The decision made by the index client or the index client's partner to enroll in PS.

Variable #

Variable Name

Variable Definition

Value Description where
applicable
Accepted
Declined

X502

Time Period for Recall (in months)

X503

Total Number of Partners Claimed

X511

Total Number of Named Partners

X511a

Total Number of Named Male Partners

X511b
X511c

Total Number of Named Female Partners
Total Number of Named Transgender
Partners

X600

Partner Notifiability

The period of time as defined in months for which the client is asked to remember and report his
or her number of sex and/or needle-sharing partners.
The total number of sex or needle-sharing partners reported by the client over a specified recall
period. This would include anonymous partners and partners for which there is not sufficient
information to locate and notify.
The total number of sex or needle-sharing partners for which there is sufficient identifying and
locating information.
The total number of sex or needle-sharing male partners for which there is sufficient identifying
and locating information.
The total number of sex or needle-sharing female partners for which there is sufficient identifying
and locating information.
The total number of sex or needle-sharing transgender partners for which there is sufficient
identifying and locating information.
An indication of whether or not a named partner is determined to be eligible for notification of
exposure. Partners that are found to be previously positive, deceased, or for which there is a risk
of domestic violence are not considered to be notifiable.
No - Partner is deceased
No - Partner is out of jurisdiction
No - Partner has a risk of domestic
violence
No - Partner is known to be
previously positive
Yes - Partner is notifiable
Other

X601

Actual Notification Method

The actual method used to notify each identified partner that they have been exposed to HIV. This
outcome may differ from the notification plan (PCR209).
Client notification
Provider notification
Dual notification
Third-party notification
Refused notification

X602

Previous HIV test

The partner's self-report of having had at least one prior HIV test before these data were
collected.
No
Yes
Not asked
Declined to answer
Don't know

X603

Self-Reported HIV Test Result

The client's self-reported test result from his/her most recent HIV test prior to notification.
Positive
Negative

Variable #

Variable Name

Variable Definition

Value Description where
applicable
Preliminary positive
Indeterminate
Not asked
Declined to answer

X604
X702
X702a

Date of Last HIV Test
Referral Date
Reason Client Not Referred to HIV Medical
Care

The date of the partner's last HIV test.
The date on which the referral was made for the client.
The reason why a referral to HIV medical care on HIV-positive client was not made.
Client already in care
Client declined care

X703_01

Referred To HIV Testing

The client was referred to HIV testing. HIV testing is a diagnostic, laboratory procedure to assess
for the presence of HIV antibodies.
No
Yes
Don't know

X703_10

Referred To Medical Care

The client was referred to medical services for (or due to their HIV positive diagnosis) HIV
infection including: evaluation of immune system function and screening, treatment, and
prevention of opportunistic infection.
No
Yes
Don't know

X703_14

Referred To Partner Services

The client was referred to Partner Services. Partner services include a range of available services
for newly and previously diagnosed HIV-infected persons, their partners and affected
communities.
No
Yes
Don't know

X703_17

Referred To HIV Prevention Services

The client was referred to HIV prevention services. Prevention services include services that
address additional prevention service or treatment needs such as health education, individual
counseling, and community level interventions.
No
Yes
Don't know

X706

Referral Outcome

The current status of the referral based on activities to verify that the service was accessed.
Pending
Confirmed - Accessed service
Confirmed - Did not access service
Lost to follow-up
No follow-up

X706b

First HIV Medical Care Appointment within
90 Days of HIV Test

Confirmation that a client attended his/her HIV medical care appointment within 90 days of the
HIV test date.

Variable #

Variable Name

Variable Definition

Value Description where
applicable
No
Yes
Don't know

X712

HIV Test Performed

A client received an HIV test as a result of a referral from PS to CTR. This variable is required for
PS referrals only.
No
Yes

X713

HIV Test Result

The confirmed outcome of an HIV test conducted on the partner as a result of a referral to HIV
testing through Partner Services (PS).This variable is required for PS only.
Positive/reactive
Negative
Indeterminate
Invalid
No result

X714a

HIV Test Results Provided

The act of informing the client of his or her HIV test result.
No
Yes

X724

Client Receive Prevention Services

Confirmation that a client received prevention services after receiving an HIV positive test result.
Prevention services is defined as generally, any service or intervention directly aimed at reducing
risk for transmitting or acquiring HIV infection.
No
Yes
Don't know

X725

Partner Service Interview

The indication that a client was interviewed for Partner Services.
No
Yes
Don't know

X725a

Was the PS Interview within 30 days of
receiving a positive HIV test result

If a client was interviewed for Partner Services, this is an indication of whether or not he/she was
interviewed within 30 days of receiving their HIV positive test result.
No
Yes
Don't know

XML01a

CT Schema Version Number

XML01b

PS Schema Version Number

XML02

Agency Id Sending XPEMS File

XML03

Date Range Included in File

Specifies the version of the XSD which has been used to validate the XML file. This ensures
proper synchronization of the validation of the XML data on both sides of the communication
channel. This only refers to the HIV testing schema.
Specifies the version of the XSD which has been used to validate the XML file. This ensures
proper synchronization of the validation of the XML data on both sides of the communication
channel. This only refers to the HIV Partner Services schema.
The agency which sent the XML data file. This field allows for better CDC management of
multiple files from multiple entities.
Specifies the data range which bounds the data and allows for better data management (duplicate
identification).

Variable #

Variable Name

Variable Definition

XML04
XML05
XML06
XML07
XML08
XML09
XML10

Data Type in File
Contact Person Information
Collection of Agency IDs Included in File
Date xPEMS XML File Was Created
Date File Last Modified
Special Instructions
Agency Name of Data Owner

Specifies the type of data being sent (e.g., Agency, Service). This helps to identify the correct
data receiving process necessary to handle the XML message.
Contact information of the person who manages the packaging and sending of the data.
The IDs of each agency for which data are being transmitted in the file.
The date the XML file was created.
If it has been modified, the last date it was modified.
Special instructions about XML file, if any.
The actual owner of the submitted XML file.

NHM&E Aggregate Level Variables
ME101a

ME101b

ME101c

Number of HIV-diagnosed MSM who
participated in a linkage to HIV medical care
program or activity
Number of HIV-diagnosed IDU who
participated in a linkage to HIV medical care
program or activity
Number of HIV-diagnosed heterosexuals
who participated in a linkage to HIV medical
care program or activity

The number of HIV-diagnosed MSM who participated in a program or activity designed to link
them to HIV medical care. Linkage to HIV medical care occurs when a client is seen by a healthcare provider to receive medical care for his/her HIV infection.
The number of HIV-diagnosed IDU who participated in a program or activity designed to link them
to HIV medical care.
The number of HIV-diagnosed heterosexuals who participated in a program or activity designed to
link them to HIV medical care.

ME101e

Number of HIV -diagnosed clients with other/
unknown behavioral risk factors who
participated in a linkage program or activity
Number of HIV-diagnosed African
Americans who participated in a linkage to
HIV medical care program or activity

ME101f

Number of HIV-diagnosed Hispanics who
participated in a linkage to HIV medical care
program or activity Database variable name: The number of HIV-diagnosed Hispanics/Latinos of any race who participated in a program or
HIVHISPlinkedtocare
activity designed to link them to HIV medical care.

ME101g

Number of HIV-diagnosed clients of other
The number of HIV-diagnosed clients of a race/ethnicity, other than blacks/African Americans,
race/ethnicity who participated in a linkage to Hispanics/Latinos, or of unknown race/ethnicity who participated in a program or activity designed
HIV medical care program or activity
to link them to HIV medical care.

ME102a

The number of HIV-diagnosed MSM who participated in a program or activity designed to increase
adherence to ART. An ART adherence program/activity is any intervention that is client-centered
and provides support and assistance to HIV-diagnosed people who are taking ART. HIV
diagnosed clients who enrolled into any of these types of programs/activities are considered to
have participated in ART adherence support program or activity.

ME101d

ME102b

Number of HIV-diagnosed MSM who
participated in an HIV medication (ART)
adherence support program/activity
Number of HIV-diagnosed IDU who
participated in an HIV medication (ART)
adherence support program/activity

The number of HIV-diagnosed clients with other behavioral risks (i.e., excluding MSM, IDU, or
heterosexuals) or unknown behavioral risks who participated in a program or activity designed to
link them to HIV medical care.
The number of HIV-diagnosed non-Hispanic blacks or African Americans who participated in a
program or activity designed to link them to HIV medical care.

The number of HIV-diagnosed IDU who participated in a program or activity designed to increase
adherence to ART.

Value Description where
applicable

Variable #

Variable Name

ME102c

Number of HIV-diagnosed heterosexuals
who participated in an HIV medication (ART) The number of HIV-diagnosed heterosexuals who participated in a program or activity designed to
adherence support program/activity
increase adherence to ART.

ME102d

ME102e

Number of HIV-diagnosed clients with other/
unknown behavioral risk factors who
participated in an HIV medication (ART)
adherence support program/activity
Number of HIV-diagnosed African
Americans who participated in an HIV
medication (ART) adherence support
program/activity

Variable Definition

The number of HIV-diagnosed clients with other behavioral risks (i.e., excluding MSM, IDU, or
heterosexuals) or unknown behavioral risks who participated in a program or activity designed to
increase adherence to ART.

The number of HIV-diagnosed non-Hispanic blacks or African Americans who participated in a
program or activity designed to increase adherence to ART.

ME102g

Number of HIV-diagnosed Hispanics who
participated in an HIV medication (ART)
adherence support program/activity
Number of HIV-diagnosed clients of another
race/enthnicity who participated in an HIV
medication (ART) adherence support
program/activity

ME103a

The number of HIV-diagnosed MSM who participated in a program or activity designed to retain or
re-engage them in HIV medical care. Participation in an a retention or re-engagement
Numbers of HIV-diagnosed MSM who
participated in a program/activity to retain/re- program/activity is defined as enrollment into any program or activity that helps HIV-diagnosed
clients keep their scheduled clinic appointments following entry into HIV medical care.
engage them into HIV medical care

ME103b

Numbers of HIV diagnosed IDU who
participated in a program/activity to retain/re- The number of HIV-diagnosed IDU who participated in a program or activity designed to retain or
engage them into HIV medical care
re-engage them in HIV medical care.

ME103c

Numbers of HIV-diagnosed heterosexuals
who participated in a program/activity to
The number of HIV-diagnosed heterosexuals who participated in a program or activity designed to
retain/re-engage them into HIV medical care retain or re-engage them in HIV medical care.

ME102f

ME103d

ME103e

Number of HIV -diagnosed clients with other/
unknown behavioral risk factors who
participated in a program/activity to retain/reengage them into HIV medical care
Numbers of HIV-diagnosed African
Americans who participated in a
program/activity to retain/re-engage them
into HIV medical care

The number of HIV-diagnosed Hispanics/Latinos of any race who participated in a program or
activity designed to increase adherence to ART.
The number of HIV-diagnosed clients of a race/ethnicity, other than blacks/African Americans,
Hispanics/Latinos, or of unknown race/ethnicity who participated in a program or activity designed
to increase adherence to ART.

The number of HIV-diagnosed clients with other behavioral risks (i.e., excluding MSM, IDU, or
heterosexuals) or unknown behavioral risks who participated in a program or activity designed to
retain or re-engage them in HIV medical care.

The number of HIV-diagnosed non-Hispanic blacks or African Americans who participated in a
program or activity designed to retain or re-engage them in HIV medical care.

Value Description where
applicable

Variable #

ME103f

ME103g
ME104

ME105a
ME105b
ME105c

Variable Name
Numbers of HIV-diagnosed Hispanics who
participated in a program/activity to retain/reengage them into HIV medical care
Number of HIV diagnosed clients of another
race/ethnicity who participated in a
program/activity to retain/re-engage them
into HIV medical care
Number of condoms distributed
Number of condoms distributed to high-risk
individuals who are HIV-negative or whose
HIV status is unknown
Number of condoms distributed to HIV
positive individuals
Number of condoms distributed to general
population

ME110

Number of Community EBI conducted
Number of people reached by community
EBI interventions

ME111

Number of social marketing conducted

ME109

ME112
ME113

ME114a
ME114b
ME114c

ME114d
ME114e

Number of people reached by social
marketing/public information events
Number of media placements for marketing
campaigns

Variable Definition

The number of HIV-diagnosed Hispanics/Latinos of any race who participated in a program or
activity designed to retain or re-engage them in HIV medical care.
The number of HIV-diagnosed clients of a race/ethnicity, other than blacks/African Americans,
Hispanics/Latinos, or of unknown race/ethnicity who participated in a program or activity designed
to retain or re-engage them in HIV medical care.
The total number of condoms distributed.

The estimated number of condoms distributed to high-risk HIV negative/unknown status clients.
The estimated number of condoms distributed to HIV positive clients.
The estimated number of condoms distributed to the general population.
The total number of number of community evidence-based interventions (EBI) conducted. A
community EBI is defined as an EBI that seeks to improve the risk conditions and behaviors in a
community through a focus on the community as a whole, rather than by intervening only with
individuals or small groups.
The estimated total number of people reached by all of the community evidence-based
interventions (EBIs).
The total number of social marketing/public Info events conducted. Social marketing/public
Information events are defined as HIV-prevention messages delivered through one or more mass
communication channels to target audiences.
The estimated total number of people exposed to a key message disseminated by a social
marketing /public information events. Exposure to marketing campaign occurs when a person
views or hears a key message disseminated by the campaign.
The total number of media placements for marketing campaigns. A media placement is the use of
various types of media to promote or advertise a particular message.

The number of MSM clients referred to non-occupational Post-Exposure Prophylaxis (nPEP)
therapy. PEP (Post-Exposure Prophylaxis) involves the medically-supervised provision of HIV
Number of MSM referred to nPEP therapy
antiretroviral drugs (ART) to HIV-negative persons who may have recently been exposed to HIV.
The number of IDU clients referred to non-occupational Post-Exposure Prophylaxis (nPEP)
Number of IDU referred to nPEP therapy
therapy.
The number of high-risk heterosexuals referred to non-occupational Post-Exposure Prophylaxis
Number of HRHET referred to nPEP therapy (nPEP) therapy.
The number of clients with other behavioral risks (i.e., excluding MSM, IDU, or high-risk
Number of clients with other risks referred to heterosexuals) or unknown behavioral risks referred to non-occupational Post-Exposure
nPEP therapy
Prophylaxis (nPEP) therapy.
Number of African Americans referred to
The number of non-Hispanic blacks or African Americans referred to non-occupational PostnPEP therapy
Exposure Prophylaxis (nPEP) therapy.

Value Description where
applicable

Variable #

Variable Name

Variable Definition

ME114f

Number of Hispanics referred to nPEP
therapy

The number of Hispanics/Latinos of any race referred to non-occupational Post-Exposure
Prophylaxis (nPEP) therapy.

ME114g

Number of clients of another race/ethnicity
referred to nPEP therapy

ME115f

The number of clients of a race/ethnicity, other than African American or Hispanic or of unknown
race/ethnicity referred to non-occupational Post-Exposure Prophylaxis (nPEP) therapy.
The number of MSM who were referred and initiated non-occupational Post-Exposure Prophylaxis
Number of MSM initiated nPEP therapy
(nPEP) therapy.
The number of IDU who were referred and initiated non-occupational Post-Exposure Prophylaxis
(nPEP) therapy.
Number of IDU initiated nPEP therapy
The number of high-risk heterosexuals who were referred and initiated non-occupational PostNumber of HR-HET initiated nPEP therapy Exposure Prophylaxis (nPEP) therapy.
The number of clients with other behavioral risks (i.e., excluding MSM, IDU, or high-risk
heterosexuals) or unknown behavioral risks who were referred to and initiated non-occupational
Number of clients with other risks initiated
Post-Exposure Prophylaxis (nPEP) therapy.
nPEP therapy
Number of African American initiated nPEP The number of non-Hispanic blacks or African Americans who were referred to and initiated Posttherapy
Exposure Prophylaxis (PEP) therapy.
The number of Hispanics/Latinos of any race who were referred to and initiated Post-Exposure
Number of Hispanics initiated nPEP therapy Prophylaxis (PEP) therapy.

ME115g

Number of clients of another race/ethnicity
initiated nPEP therapy

ME115a
ME115b
ME115c

ME115d
ME115e

ME117b

Number of African American MSM clients
referred to PrEP therapy
Number of Hisp MSM referred to PrEP
therapy
Number of MSM of another race/ethnicity
referred to PrEP therapy
Number of African American MSM Clients
initiated PrEP therapy
Number of Hispanic clients initiated PrEP
therapy

ME117c

Number of MSM of another race/ethnicity
initiated PrEP therapy

ME116a
ME116b
ME116c
ME117a

The number of clients of a race/ethnicity, other than African American or Hispanic, or of unknown
race/ethnicity who were referred to and initiated Post-Exposure Prophylaxis (PEP) therapy.
The number of high-risk non-Hispanic black or African American MSM referred to Pre-Exposure
Prophylaxis (PrEP) therapy. PrEP may be part of comprehensive HIV prevention services in
which HIV negative people who are at high risk, take antiretroviral medication daily to try to lower
their chances of becoming infected with HIV if they are exposed to it.
The number of Hispanics/Latinos of any race MSM referred to Pre-Exposure Prophylaxis (PrEP)
therapy.
The number of MSM clients of a race/ethnicity, other than African American or Hispanic, or of
unknown race/ethnicity were referred to Pre-Exposure Prophylaxis (PrEP) therapy.
The number of non-Hispanic blacks or African Americans MSM who were referred and initiated
Pre-Exposure Prophylaxis (PrEP) therapy.
The number of Hispanics/Latinos of any race MSM who were referred and initiated Pre-Exposure
Prophylaxis (PrEP) therapy.
The number of MSM clients of a race/ethnicity, other than Blacks/African Americans,
Hispanics/Latino, or of unknown race/ethnicity who were referred and initiated Pre-Exposure
Prophylaxis (PrEP) therapy.

NHM&E Budget Allocation Variables

BT101a

For PS12-1201 Category A award (HIV Prevention Programs for Health Departments), this value
represents the allocation associated with routine HIV testing or screening. Routine HIV testing or
Amount of PS12-1201 Category A funds
screening is a testing strategy that involves testing persons regardless of whether they have a
allocated for routine HIV testing or screening recognized behavioral risk or presence of signs or symptoms of HIV infection.

Value Description where
applicable

Variable #

Variable Name

BT101b

For PS12-1201 Category B award (Expanded HIV Testing for Disproportionately Affected
Populations), this value represents the allocation associated with routine HIV testing or screening
Amount of PS12-1201 Category B funds
allocated for routine HIV testing or screening performed in your area using Category B funds.

BT101c

BT101d

BT102a

Amount of PS12-1201 Category C funds
allocated for routine HIV testing or screening
Amount of CDC funds other than PS12-1201
award allocated for routine HIV testing or
screening

Amount of PS12-1201 Category A funds
allocated for targeted HIV testing

BT102k

Amount of PS12-1201 Category B funds
allocated for targeted HIV testing
Amount of PS12-1201 Category C funds
allocated for targeted HIV testing
Amount of CDC funds other than from PS121201 award that was allocated for targeted
HIV testing
Amount of all CDC funds allocated to
provide targeted HIV testing to MSM
Amount from all CDC funds allocated to
provide targeted HIV testing to IDU
Amount of all CDC funds allocated to
provide targeted HIV testing to
heterosexuals
Amount of all CDC funds allocated to
provide targeted HIV testing to clients of
other/unknown behavioral risks
Amount of all CDC funds allocated to
provide targeted HIV testing to African
Americans
Amount of all CDC funds allocated to
provide targeted HIV testing to Hispanics
Amount of all CDC funds allocated to
provide targeted HIV testing to clients of
other or unknown race

BT102l

Open-ended question 1 for Targeted HIV
testing

BT102b
BT102c

BT102d
BT102e
BT102f

BT102g

BT102h

BT102i
BT102j

Variable Definition

For PS12-1201 Category C award (Demonstration Projects), this value represents the funds
allocated from your Category C award that are for routine HIV testing or screening.
For all CDC funds excluding PS12-1201 award, this value represents the funds allocated for
routine HIV testing or screening that uses funding sources other than from PS12-1201.
For PS12-1201 Category A award (HIV Prevention Programs for Health Departments), this value
represents the allocation associated with targeted HIV testing. Targeted HIV testing is a testing
strategy that involves testing persons based on characteristics that increase their likelihood of
being infected with HIV. These characteristics can include the presence of sexually transmitted
diseases, behavioral risks, or attendance at venues frequented by high-risk persons.
For PS12-1201 Category B award (Expanded HIV Testing for Disproportionately Affected
Populations), this value represents the allocation associated with targeted HIV testing at nonhealth-care setting (optional).
For PS12-1201 Category C award (Demonstration Projects), this value represents the allocation
associated with targeted HIV testing.
For all CDC funds excluding PS12-1201, this value represents the allocation associated with
targeted HIV testing.
For all CDC funds allocated to targeted HIV testing, this value represents allocation for MSM.
From all CDC funds allocated to targeted HIV testing, this value represents allocation for IDU.
For all CDC funds allocated to targeted HIV testing, this value represents allocation for
heterosexuals.
For all CDC funds allocated to targeted HIV testing, this value represents allocation for clients with
other (i.e., excluding MSM, IDU, or heterosexuals) or unknown behavioral risks.
For all CDC funds allocated to targeted HIV testing, this value represents allocation for nonHispanic blacks or African Americans.
For all CDC funds allocated to targeted HIV testing, this value represents allocation for
Hispanics/Latinos of any race.
For all CDC funds allocated to targeted HIV testing, this value represents allocation for clients of a
race/ethnicity, other than blacks/African Americans, Hispanics/Latinos, or of unknown
race/ethnicity.
If you are unable to report funding allocations for targeted HIV testing by risk group or by
race/ethnicity (above categories), please provide a brief explanation of any limitations to providing
this level of detail.

Value Description where
applicable

Variable #

Variable Name

BT102m

Open-ended question 2 for Targeted HIV
testing

BT103a

BT103b

BT103c

BT103d
BT103e

BT103f
BT103g

BT103h
BT103i
BT103j
BT104a
BT104b

BT104c

BT104d

Variable Definition

Please provide any additional information to explain funding allocation limitations or caveats for
HIV testing that may be a concern to you, if applicable.
For PS12-1201 Category A award (HIV Prevention Programs for Health Departments); this value
represents the funding allocation associated with comprehensive prevention with positives (CPP)
programs and services. CPP covers a range of prevention activities including Partner Services,
Amount of PS12-1201 Category A funds
continuum of care (linkage, retention, re-engagement in care, and treatment adherence), riskallocated for comprehensive prevention with reduction EBIs with HIV-positive people and other prevention programs that are targeted to HIVpositives
diagnosed individuals and their partners.
Amount of PS12-1201 Category B funds
For PS12-1201 Category B award (Expanded HIV Testing for Disproportionately Affected
allocated for comprehensive prevention with Populations); this value represents the funding allocation associated with comprehensive
positives
prevention with positives (CPP) programs and services.
Amount of PS12-1201 Category C funds
For PS12-1201 Category C award (HIV Prevention Programs for Health Departments); this value
allocated for comprehensive prevention with represents the funding allocation associated with comprehensive prevention with positives (CPP)
positives
programs and services.
Amount of CDC funds other than PS12-1201
allocated for comprehensive prevention with For CDC funds other than PS12-1201, this value represents the allocation associated with
positives
comprehensive prevention with positives (CPP).
Amount of all CDC funds allocated to
Partner Services
For all CDC funding, this value represents the allocation associated with Partner Services.
For all CDC funding, this value represents the allocation associated with HIV continuum of care.
Amount of all CDC funds allocated to HIV
HIV continuum of care activities include linkage, retention, and re-engagement in care, and HIV
continuum of care
medication adherence support.
Amount of all CDC funds allocated to Risk- For all CDC funding, this value represents the allocation associated with risk-reduction EBIs with
Reduction EBIs with Positives
HIV positive people.
For all CDC funding, this value represents the allocation associated with comprehensive
Amount of all CDC funds allocated to other prevention with positive activities other than Partner services, continuum of care and riskCPP activities
reduction EBIs with HIV positive people.
Open-ended question 1 for comprehensive Please identify the specific prevention activities included in the allocations to “other CPP” activities
prevention with positives
category.
Open-ended question 2 for comprehensive Please provide any additional information to explain CPP-related funding allocation limitations or
prevention with positives
caveats that may be a concern to you, if applicable.
Amount of PS12-1201 Category A funding
For PS12-1201 Category A award (HIV Prevention Programs for Health Departments), this value
allocated for condom distribution
represents the funding allocation associated with condom distribution.
Amount of CDC funds other than PS12-1201 For CDC funds other than PS12-1201, this value represents the allocation associated with
allocated to condom distribution
condom distribution.
Amount of all CDC funds allocated to
condom distribution targeting HIV positives
Amount of all CDC funds allocated to
condom distribution targeting high-risk
individuals who are HIV-negative or whose
HIV status is unknown

For all CDC funds, this value represents the allocation associated with condom distribution that
was targeting HIV-positive individuals.

For all CDC funds, this value represents the allocation associated with condom distribution that
was targeting high-risk individuals with HIV-negative or unknown status.

Value Description where
applicable

Variable #

BT104e
BT104f
BT104g
BT105a
BT105b

BT106a

BT106b

BT106c

BT106d

BT106e

BT106f

BT107a

BT107b
BT108a

BT108b

Variable Name

Variable Definition

Amount of all CDC funds allocated to
condom distribution targeting the general
population
Open-ended question 1 for condom
distribution
Open-ended question 2 for condom
distribution
Amount of PS12-1201 Category A allocated
for Policy Initiatives
Amount of CDC funds other than PS12-1201
allocated for Policy Initiatives

For all CDC funds, this value represents the allocation associated with condom distribution that
was targeting the general population.
If you are unable to report allocations to condom distribution for the three groups, please provide a
brief explanation of any limitations to providing this level of detail.
Please provide any additional information to explain condom distribution-related funding allocation
limitations or caveats that may be a concern to you, if applicable.
For PS12-1201 Category A award (HIV Prevention Programs for Health Departments), this value
represents the allocation associated with policy initiatives.
For CDC funds other than PS12-1201, this value represents the allocation associated with Policy
Initiatives.

For PS12-1201 Category A award (HIV Prevention Programs for Health Departments); this value
represents the allocation associated with all PS12-1201 recommended components (RC). RC
Amount of PS12-1201 Category A funds
includes Evidence-based HIV Prevention Interventions for HIV-Negative Persons at Highest Risk
allocated for all PS12-1201 recommended
of Acquiring HIV, social marketing, media, and mobilization, and Pre-exposure prophylaxis and
components
Non-occupational post-exposure prophylaxis services.
For PS12-1201Category B award (Expanded HIV Testing for Disproportionately Affected
Amount of PS12-1201 Category B allocated Populations), this value represents the allocation associated with the optional services integration
component.
for service integration (optional)
Amount of CDC funds other than PS12-1201
allocated for all recommended components
Open-ended question for PS 12-1201
Category A funds allocated for
Recommended Components
Open-ended question for PS12-1201
Category B funds allocated for Optional
Components
Open-ended question for CDC funds other
than PS 12-1201 allocated for
Recommended Components
Amount of PS12-1201 funds allocated for
HIV prevention program monitoring and
evaluation
Amount of CDC funds other than PS12-1201
allocated for program monitoring and
evaluation
Amount of PS12-1201 funding allocated for
Jurisdictional HIV Prevention Planning
Amount of CDC funds other than PS12-1201
allocated for Jurisdictional HIV Prevention
Planning

For CDC funds other than PS12-1201, this value represents the annual allocation associated with
all recommended components (RC).
If you have allocated PS12-1201 category A to recommended components, please give a brief list
of programs or activities that you are going to implement.
If you have allocated PS12-1201 category A to optional components, please give a brief list of
programs or activities that you implement.
If you have allocated CDC funds other than PS 12-1201 to recommended components, please
give a brief list of programs or activities that you implement.
For PS12-1201, this value represents the allocation associated with program monitoring and
evaluation.
For CDC funds other than PS12-1201, this value represents the allocation associated with
program monitoring and evaluation.
For PS12-1201, this value represents the allocation associated with jurisdictional HIV prevention
planning.
For CDC funds other than PS12-1201, this value represents the allocation associated with
jurisdictional HIV prevention planning.

Value Description where
applicable

Variable #

Variable Name

Variable Definition

Amount of PS12-1201 funding allocated for
Capacity Building and Technical Assistance
Amount of CDC funds other than PS12-1201
allocated for Capacity Building and
Technical Assistance

For PS12-1201, this value represents the allocation associated with capacity building and
technical assistance.

For PS12-1201, this value represents the allocation associated with agency's general operations
or administrative activities.

BT110b

Amount PS12-1201 allocated for agency's
general operations or admin activities
Amount CDC funds other than PS12-1201
allocated for agency's general operations or
admin activities

BT111

Open-ended question for overall budget
allocation

Please provide any additional information to explain funding allocation limitations or caveats that
may be a concern to you, if applicable, for any of the budget allocation variables.

BT109a

BT109b

BT110a

Value Description where
applicable

For CDC funds other than PS12-1201, this value represents the allocation associated with
capacity building and technical assistance.

For CDC funds other than PS12-1201, this value represents the allocation associated with
agency's general operations or administrative activities.

NHM&E Community-Based Organization Specific Variables - Client, Aggregate, and Targets
CLIENT-LEVEL VARIABLES
EDate
Date of enrollment
CompEBI
Completed Intervention

The calendar month, day, and year on which the client enrolls in the intervention.
Whether or not a client completes an intervention.
Yes
No

HIVpos

HIV positive

A client’s self-report of whether he or she has received a positive HIV test result.
Yes
No
Declined to anser
Client doesn't know

CONDATE

Condom distribution

BEREF

Basic education continuation and/or
The calendar month, day, and year of each referral for basic education and/or completion services
completion services
that a client receives.
Behavioral interventions for HIV prevention The calendar month, day, and year of each referral for behavioral interventions for HIV prevention
that a client receives.
Dental Care
The calendar month, day, and year of each referral for dental care that a client receives.
Employment and readiness and referral
The calendar month, day, and year of each referral for employment and readiness and referral
programs
programs that a client receives.
Food/clothing/other basic needs
The calendar month, day, and year of each referral for food, clothing and/or other basic needs
that a client receives.
HIV testing
The calendar month, day, and year of each referral for HIV testing that a client receives.

BIREF
DCREF
EREF
FREF
HIVREF

The calendar month, day, and year on which a client first receives condoms in conjunction with
another HIV prevention service (i.e., HIV prevention intervention, referral to HIV prevention and
support services, referrals and linkage specifically for positives).

Variable #
HREF

Variable Name
Housing services

Variable Definition
The calendar month, day, and year of each referral for housing services that a client receives.

IREF

Insurance enrollment

The calendar month, day, and year of each referral for insurance enrollment that a client receives.

MHREF

Mental health services program

PEPREF

Post-exposure prophylaxis

PREREF

Pre-exposure prophylaxis

PHREF

Primary health care

The calendar month, day, and year of each referral for mental health services that a client
receives.
The calendar month, day, and year of each referral for post-exposure prophylaxis that a client
receives.
The calendar month, day, and year of each referral for pre-exposure prophylaxis that a client
receives.
The calendar month, day, and year of each referral for primary health care that a client receives.

HEPREF

Screening and/or treatment for Hepatitis

STDREF

Screening and/or treatment for STDs

SAREF
TBREF

Screening and/or treatment for substance
abuse
Screening and/or treatment for TB

SGREF

Support groups

SSREF

Syringe services program

TTREF

Transgender transition support services

OSREF

Specify other service

ODATE

Other services

DISDATE

Discussion Date

DIAGDATE
MEDCARE

Date of HIV positive diagnosis
Client currently in HIV medical care

Value Description where
applicable

The calendar month, day, and year of each referral for screening and/or treatment for Hepatitis
that a client receives.
The calendar month, day, and year of each referral for screening and/or treatment for STDs that a
client receives.
The calendar month, day, and year of each referral for screening and/or treatment for substance
abuse that a client receives.
The calendar month, day, and year of each referral for screening and/or treatment for TB that a
client receives.
The calendar month, day, and year of each referral for support groups that a client receives.
The calendar month, day, and year of each referral for a syringe services program that a client
receives.
The calendar month, day, and year of each referral for transgender transition support services
that a client receives.
Description of a service for which the client received a referral. The service cannot be classified by
one of the previously specified referral categories.
The calendar month, day, and year of each referral for the specified service that a client receives.
The calendar month, day, and year that CBO staff initiate discussion of referral and linkage to HIV
medical care with client.
The calendar month and year that a client received a positive HIV test result.
A client’s self-report of whether he or she is currently seeing an HIV medical care provider.
Yes
No
Declined to answer

REFCARE

Referred to HIV medical care

CBO report of whether CBO staff referred a client who is not currently in care to HIV medical care.

Variable #

Variable Name

Variable Definition

MEDDATE

Date of first medical appointment

LTCREF

Evidence-based linkage to care activity

RMEDDATE

HIV Medical Care (after unsuccessful initial
attempt to refer and/or link to care, or for
client who needs to be re-engaged in care)

The calendar month, day, and year on which the client attends his or her first medical
appointment after referral is made by the CBO.
The calendar month, day, and year of each referral that a client receives for an evidence-based
linkage to care activity.
The calendar month, day, and year of each referral that a client receives for HIV medical care after
an unsuccessful initial attempt to refer and/or link to care, or for a client who needs to be reengaged in care.

PSREF

Partner services

TAREF
OSPREF

Treatment adherence services, including
adherence to ARV
Specify other service

OPDATE

Other services

AGGREGATE-LEVEL VARIABLES
PEERED
Peer Educators

The calendar month, day, and year of each referral that a client receives for partner services given
to the client.
The calendar month, day, and year of each referral that a client receives for treatment adherence
services, including adherence to ARV.
Description of the service for positives that the client received a referral for. The service cannot
be classified by one of the previously specified referrals for postives.
The calendar month, day, and year of each referral that a client receives for other services
(OSPREF) given to the client.

RCONV

Risk Conversations

SMMEDIA

Small media

OUTREACH

Formal outreach events

CONCLI

Condoms distributed as part of CLI

CONTOT
CONNEG

Total condoms purchased
Condoms distributed for high-risk
negative/HIV status unknown persons

CONPOS

Condoms distributed for HIV positive
persons

Number of peer educators who attended all required training sessions as planned (according to
EBI guidance or approved adaptation)
Number of conversations conducted by trained peer educators that include risk reduction
messaging.
Total number of outreach materials distributed to the target population that promote HIV risk
reduction.
Number of outreach events planned and conducted where safer sex or HIV risk reduction is
promoted.
Total number of condoms that are distributed specifically as part of the community-level
intervention.
Total number of all condoms bought using PS11-1113 funding.
Number of condoms that were provided during activities approved by and paid for by PS11-1113
funding intended to reach persons at high-risk of acquiring HIV who are currently HIV negative or
unaware of their HIV status.
Number of condoms that were provided during activities approved by and paid for by PS11-1113
funding intended to reach persons who are HIV positive.

Target for HIV testing events

Number of HIV testing events the CBO plans to provide to clients.

TARGETS
THIVTST

Value Description where
applicable
Yes
No, referral offered, but client
declined
No, another reason

Variable #
TNEWPOS

Variable Name
Variable Definition
Target for newly-identified HIV positive tests Percentage of total testing events that will be associated with a newly-identified HIV infection.

TRECRES

Target for receipt of results

TMGRAPP

Percentage of total newly-identified HIV positive testing events for which clients will receive their
HIV positive test result.
Target for referral to HIV medical care (test- Percentage of total newly-identified HIV positive testing events for which clients will receive a
level)
referral to HIV medical care. This target is set only for referrals provided through HIV testing
events.
Target for linkage to HIV medical care (test- Percentage of total newly-identified HIV positive testing events for which clients will be linked to
level)
HIV medical care (i.e., referred to HIV medical care and attended first appointment within 3
months of diagnosis). This target is set only for linkage to care provided through HIV testing
events.
Target for referral to Partner Services
Percentage of total newly-identified HIV positive testing events for which clients will be referred
to Partner Services. This target is set only for referral to Partner Services provided through HIV
testing events.
Target for referral to prevention services
Percentage of total newly-identified HIV positive testing events for which clients will be referred
to prevention services. This target is set only for referral to prevention services provided through
HIV testing events.
Target for intervention enrollment
Number of clients that will be enrolled in each HIV prevention intervention that the CBO is funded
to conduct.
Target for intervention completion
Percentage of clients enrolled in each intervention that will complete the intervention (according
to EBI guidance or approved adaptation).
Target for intervention enrollment of HIV
Percentage of clients who will enroll in each intervention who are HIV positive.
positives
Target for MGroup and RAPP completion
Number of clients that will be enrolled in the M group and RAPP HIV informational sessions.

TPEERED

Target for peer educator training

TRISKRED

Target for risk reduction conversations

TSMMED

Target for small media

TOUTREAC

Target for formal outreach

TCONCLI

Target for condom distribution for CLIs

TCONDATE

Target for client-level condom distribution

TCONTOT

Target for total condoms purchased

TNEWREF

TNEWLINK

TREFPS

TREFPRS

TENRINT
TCOMPINT
TENRPOS

Number of peer educators who will attend all required training sessions as planned (according to
EBI guidance or approved adaptation).
Number of conversations conducted by trained peer educators that include risk reduction
messaging that will take place (e.g., informal outreach, stage-based encounters).
Total number of outreach materials that will be distributed to the target population that promote
HIV risk reduction.
Number of outreach events planned and conducted where safer sex or HIV risk reduction is
promoted.
Number of condoms that will be distributed specifically as part of the community-level
intervention.
Percentage of the total number of clients receiving at least one PS 11-1113 funded program
activity (e.g., HIV prevention intervention, referral, or linkage to HIV medical care) who will be
provided condoms.
Total number of condoms that will be purchased through PS 11-1113 funds.

Value Description where
applicable

Variable #
TREFCARE
TMEDDATE

Variable Name
Target for HIV positives referred to HIV
medical care (client-level)
Target for HIV positives linked to HIV
medical care (client-level)

Value Description where
applicable
Variable Definition
Percentage of HIV positive clients receiving referrals and linkage specifically for positives who are
not yet in HIV medical care who will be referred to HIV medical care.
Percentage of HIV positive clients who are referred to HIV medical care who will attend their HIV
medical care appointment.

Codes for Variable A02
AL
01
AK
02
AZ
04
AR
05
CA
06
CO
08
CT
09
DE
10
DC
11
FL
12
GA
13
HI
15
ID
16
IL
17
IN
18
IA
19
KS
20
KY
21
LA
22
ME
23
MD
24
MA
25
MI
26
MN
27
MS
28
MO
29
MT
30
NE
31
NV
32
NH
33
NJ
34
NM
35
NY
36
NC
37
ND
38
OH
39
OK
40
OR
41
PA
42
RI
44
SC
45
SD
46
TN
47
TX
48
UT
49
VT
50

Codes for Variables S09 and G120
AL
01
AK
02
AZ
04
AR
05
CA
06
CO
08
CT
09
DE
10
DC
11
FL
12
GA
13
HI
15
ID
16
IL
17
IN
18
IA
19
KS
20
KY
21
LA
22
ME
23
MD
24
MA
25
MI
26
MN
27
MS
28
MO
29
MT
30
NE
31
NV
32
NH
33
NJ
34
NM
35
NY
36
NC
37
ND
38
OH
39
OK
40
OR
41
PA
42
RI
44
SC
45
SD
46
TN
47
TX
48
UT
49
VT
50

51
53
54
55
56
60
64
66
68
69
70
72
78

VA
WA
WV
WI
WY
AS
FM
GU
MH
MP
PW
PR
VI

80
81
82
83
84
85
86
87
88
89
90

San Francisco, CA
Los Angeles, CA
New York City, NY
Houston, TX
Chicago, IL
Philadelphia, PA
Atlanta, GA
Baltimore, MD
Dallas, TX
Miami, FL
San Juan, PR

91

Fort Lauderdale, FL

51
53
54
55
56
60
64
66
68
69
70
72
78

VA
WA
WV
WI
WY
AS
FM
GU
MH
MP
PW
PR
VI